Global Oncology Ablation

Oncology Ablation Comprehensive Study by Type (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU)), Application (Liver Cancer, Kidney Cancer, Prostate Cancer, Bone Cancer, Lung Cancer, Others), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others) Players and Region - Global Market Outlook to 2030

Oncology Ablation Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Market Snapshot:
The oncology ablation market is rapidly expanding due to the rising incidence of cancer worldwide and the growing preference for minimally invasive treatment options. Techniques such as radiofrequency, microwave, cryoablation, and laser ablation are gaining traction for their ability to target tumors with precision while minimizing damage to surrounding tissues. This shift towards less invasive procedures is driven by patient demand for quicker recovery times and reduced complications, making ablation an attractive alternative to traditional surgical methods.

Highlights from Oncology Ablation Market Study
AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The key Players profiled in the report are Varian Medical Systems, Inc., Johnson & Johnson Services Inc., Medtronic, Boston Scientific Corporation, Marcus Med, Olympus, Stryker, Canyon Medical Inc., Surgnova and Hologic, Inc.. Additionally, other players that are part of this comprehensive study are Merit Medical Systems, Terumo Corporation, AngioDynamics, Francis Medical, Inc., Sonablate Corp. and Vascular & International Partners.

Geographic Breakdown and Segment Analysis
The Global Oncology Ablation market presents a comprehensive analysis of the Oncology Ablation market by product type (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Laser Ablation and High-Intensity Focused Ultrasound (HIFU)), by end-user/application (Liver Cancer, Kidney Cancer, Prostate Cancer, Bone Cancer, Lung Cancer and Others), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Oncology Ablation industry. Investors and Players can easily understand the inherent opportunities and challenges for their products in geographical region of interest. For instance, while the holds majority of market share of the Oncology Ablation market

Analyst at AMA have segmented the market study of Global Oncology Ablation market by Type, Application and Region.

Market Growth Drivers:
Global increase in cancer cases fuels demand for effective treatment options and Innovations in ablation techniques

Challenges:
High initial investment for advanced ablation technologies

Opportunities:
Growing preference for minimally invasive procedures among patients and healthcare providers





Report Objectives / Segmentation Covered

By Type
  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Laser Ablation
  • High-Intensity Focused Ultrasound (HIFU)
By Application
  • Liver Cancer
  • Kidney Cancer
  • Prostate Cancer
  • Bone Cancer
  • Lung Cancer
  • Others
By End User
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global increase in cancer cases fuels demand for effective treatment options
      • 3.2.2. Innovations in ablation techniques
    • 3.3. Market Challenges
      • 3.3.1. High initial investment for advanced ablation technologies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Oncology Ablation, by Type, Application, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Oncology Ablation (Value)
      • 5.2.1. Global Oncology Ablation by: Type (Value)
        • 5.2.1.1. Radiofrequency Ablation
        • 5.2.1.2. Microwave Ablation
        • 5.2.1.3. Cryoablation
        • 5.2.1.4. Laser Ablation
        • 5.2.1.5. High-Intensity Focused Ultrasound (HIFU)
      • 5.2.2. Global Oncology Ablation by: Application (Value)
        • 5.2.2.1. Liver Cancer
        • 5.2.2.2. Kidney Cancer
        • 5.2.2.3. Prostate Cancer
        • 5.2.2.4. Bone Cancer
        • 5.2.2.5. Lung Cancer
        • 5.2.2.6. Others
      • 5.2.3. Global Oncology Ablation by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Specialty Clinics
        • 5.2.3.3. Ambulatory Surgical Centers
        • 5.2.3.4. Others
      • 5.2.4. Global Oncology Ablation Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Oncology Ablation: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Varian Medical Systems, Inc.
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Johnson & Johnson Services Inc.
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Medtronic
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Boston Scientific Corporation
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Marcus Med
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Olympus
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Stryker
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Canyon Medical Inc.
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Surgnova
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Hologic, Inc.
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Oncology Ablation Sale, by Type, Application, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Oncology Ablation (Value)
      • 7.2.1. Global Oncology Ablation by: Type (Value)
        • 7.2.1.1. Radiofrequency Ablation
        • 7.2.1.2. Microwave Ablation
        • 7.2.1.3. Cryoablation
        • 7.2.1.4. Laser Ablation
        • 7.2.1.5. High-Intensity Focused Ultrasound (HIFU)
      • 7.2.2. Global Oncology Ablation by: Application (Value)
        • 7.2.2.1. Liver Cancer
        • 7.2.2.2. Kidney Cancer
        • 7.2.2.3. Prostate Cancer
        • 7.2.2.4. Bone Cancer
        • 7.2.2.5. Lung Cancer
        • 7.2.2.6. Others
      • 7.2.3. Global Oncology Ablation by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Specialty Clinics
        • 7.2.3.3. Ambulatory Surgical Centers
        • 7.2.3.4. Others
      • 7.2.4. Global Oncology Ablation Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Oncology Ablation: by Type(USD Million)
  • Table 2. Oncology Ablation Radiofrequency Ablation , by Region USD Million (2018-2023)
  • Table 3. Oncology Ablation Microwave Ablation , by Region USD Million (2018-2023)
  • Table 4. Oncology Ablation Cryoablation , by Region USD Million (2018-2023)
  • Table 5. Oncology Ablation Laser Ablation , by Region USD Million (2018-2023)
  • Table 6. Oncology Ablation High-Intensity Focused Ultrasound (HIFU) , by Region USD Million (2018-2023)
  • Table 7. Oncology Ablation: by Application(USD Million)
  • Table 8. Oncology Ablation Liver Cancer , by Region USD Million (2018-2023)
  • Table 9. Oncology Ablation Kidney Cancer , by Region USD Million (2018-2023)
  • Table 10. Oncology Ablation Prostate Cancer , by Region USD Million (2018-2023)
  • Table 11. Oncology Ablation Bone Cancer , by Region USD Million (2018-2023)
  • Table 12. Oncology Ablation Lung Cancer , by Region USD Million (2018-2023)
  • Table 13. Oncology Ablation Others , by Region USD Million (2018-2023)
  • Table 14. Oncology Ablation: by End User(USD Million)
  • Table 15. Oncology Ablation Hospitals , by Region USD Million (2018-2023)
  • Table 16. Oncology Ablation Specialty Clinics , by Region USD Million (2018-2023)
  • Table 17. Oncology Ablation Ambulatory Surgical Centers , by Region USD Million (2018-2023)
  • Table 18. Oncology Ablation Others , by Region USD Million (2018-2023)
  • Table 19. South America Oncology Ablation, by Country USD Million (2018-2023)
  • Table 20. South America Oncology Ablation, by Type USD Million (2018-2023)
  • Table 21. South America Oncology Ablation, by Application USD Million (2018-2023)
  • Table 22. South America Oncology Ablation, by End User USD Million (2018-2023)
  • Table 23. Brazil Oncology Ablation, by Type USD Million (2018-2023)
  • Table 24. Brazil Oncology Ablation, by Application USD Million (2018-2023)
  • Table 25. Brazil Oncology Ablation, by End User USD Million (2018-2023)
  • Table 26. Argentina Oncology Ablation, by Type USD Million (2018-2023)
  • Table 27. Argentina Oncology Ablation, by Application USD Million (2018-2023)
  • Table 28. Argentina Oncology Ablation, by End User USD Million (2018-2023)
  • Table 29. Rest of South America Oncology Ablation, by Type USD Million (2018-2023)
  • Table 30. Rest of South America Oncology Ablation, by Application USD Million (2018-2023)
  • Table 31. Rest of South America Oncology Ablation, by End User USD Million (2018-2023)
  • Table 32. Asia Pacific Oncology Ablation, by Country USD Million (2018-2023)
  • Table 33. Asia Pacific Oncology Ablation, by Type USD Million (2018-2023)
  • Table 34. Asia Pacific Oncology Ablation, by Application USD Million (2018-2023)
  • Table 35. Asia Pacific Oncology Ablation, by End User USD Million (2018-2023)
  • Table 36. China Oncology Ablation, by Type USD Million (2018-2023)
  • Table 37. China Oncology Ablation, by Application USD Million (2018-2023)
  • Table 38. China Oncology Ablation, by End User USD Million (2018-2023)
  • Table 39. Japan Oncology Ablation, by Type USD Million (2018-2023)
  • Table 40. Japan Oncology Ablation, by Application USD Million (2018-2023)
  • Table 41. Japan Oncology Ablation, by End User USD Million (2018-2023)
  • Table 42. India Oncology Ablation, by Type USD Million (2018-2023)
  • Table 43. India Oncology Ablation, by Application USD Million (2018-2023)
  • Table 44. India Oncology Ablation, by End User USD Million (2018-2023)
  • Table 45. South Korea Oncology Ablation, by Type USD Million (2018-2023)
  • Table 46. South Korea Oncology Ablation, by Application USD Million (2018-2023)
  • Table 47. South Korea Oncology Ablation, by End User USD Million (2018-2023)
  • Table 48. Taiwan Oncology Ablation, by Type USD Million (2018-2023)
  • Table 49. Taiwan Oncology Ablation, by Application USD Million (2018-2023)
  • Table 50. Taiwan Oncology Ablation, by End User USD Million (2018-2023)
  • Table 51. Australia Oncology Ablation, by Type USD Million (2018-2023)
  • Table 52. Australia Oncology Ablation, by Application USD Million (2018-2023)
  • Table 53. Australia Oncology Ablation, by End User USD Million (2018-2023)
  • Table 54. Rest of Asia-Pacific Oncology Ablation, by Type USD Million (2018-2023)
  • Table 55. Rest of Asia-Pacific Oncology Ablation, by Application USD Million (2018-2023)
  • Table 56. Rest of Asia-Pacific Oncology Ablation, by End User USD Million (2018-2023)
  • Table 57. Europe Oncology Ablation, by Country USD Million (2018-2023)
  • Table 58. Europe Oncology Ablation, by Type USD Million (2018-2023)
  • Table 59. Europe Oncology Ablation, by Application USD Million (2018-2023)
  • Table 60. Europe Oncology Ablation, by End User USD Million (2018-2023)
  • Table 61. Germany Oncology Ablation, by Type USD Million (2018-2023)
  • Table 62. Germany Oncology Ablation, by Application USD Million (2018-2023)
  • Table 63. Germany Oncology Ablation, by End User USD Million (2018-2023)
  • Table 64. France Oncology Ablation, by Type USD Million (2018-2023)
  • Table 65. France Oncology Ablation, by Application USD Million (2018-2023)
  • Table 66. France Oncology Ablation, by End User USD Million (2018-2023)
  • Table 67. Italy Oncology Ablation, by Type USD Million (2018-2023)
  • Table 68. Italy Oncology Ablation, by Application USD Million (2018-2023)
  • Table 69. Italy Oncology Ablation, by End User USD Million (2018-2023)
  • Table 70. United Kingdom Oncology Ablation, by Type USD Million (2018-2023)
  • Table 71. United Kingdom Oncology Ablation, by Application USD Million (2018-2023)
  • Table 72. United Kingdom Oncology Ablation, by End User USD Million (2018-2023)
  • Table 73. Netherlands Oncology Ablation, by Type USD Million (2018-2023)
  • Table 74. Netherlands Oncology Ablation, by Application USD Million (2018-2023)
  • Table 75. Netherlands Oncology Ablation, by End User USD Million (2018-2023)
  • Table 76. Rest of Europe Oncology Ablation, by Type USD Million (2018-2023)
  • Table 77. Rest of Europe Oncology Ablation, by Application USD Million (2018-2023)
  • Table 78. Rest of Europe Oncology Ablation, by End User USD Million (2018-2023)
  • Table 79. MEA Oncology Ablation, by Country USD Million (2018-2023)
  • Table 80. MEA Oncology Ablation, by Type USD Million (2018-2023)
  • Table 81. MEA Oncology Ablation, by Application USD Million (2018-2023)
  • Table 82. MEA Oncology Ablation, by End User USD Million (2018-2023)
  • Table 83. Middle East Oncology Ablation, by Type USD Million (2018-2023)
  • Table 84. Middle East Oncology Ablation, by Application USD Million (2018-2023)
  • Table 85. Middle East Oncology Ablation, by End User USD Million (2018-2023)
  • Table 86. Africa Oncology Ablation, by Type USD Million (2018-2023)
  • Table 87. Africa Oncology Ablation, by Application USD Million (2018-2023)
  • Table 88. Africa Oncology Ablation, by End User USD Million (2018-2023)
  • Table 89. North America Oncology Ablation, by Country USD Million (2018-2023)
  • Table 90. North America Oncology Ablation, by Type USD Million (2018-2023)
  • Table 91. North America Oncology Ablation, by Application USD Million (2018-2023)
  • Table 92. North America Oncology Ablation, by End User USD Million (2018-2023)
  • Table 93. United States Oncology Ablation, by Type USD Million (2018-2023)
  • Table 94. United States Oncology Ablation, by Application USD Million (2018-2023)
  • Table 95. United States Oncology Ablation, by End User USD Million (2018-2023)
  • Table 96. Canada Oncology Ablation, by Type USD Million (2018-2023)
  • Table 97. Canada Oncology Ablation, by Application USD Million (2018-2023)
  • Table 98. Canada Oncology Ablation, by End User USD Million (2018-2023)
  • Table 99. Mexico Oncology Ablation, by Type USD Million (2018-2023)
  • Table 100. Mexico Oncology Ablation, by Application USD Million (2018-2023)
  • Table 101. Mexico Oncology Ablation, by End User USD Million (2018-2023)
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Oncology Ablation: by Type(USD Million)
  • Table 113. Oncology Ablation Radiofrequency Ablation , by Region USD Million (2025-2030)
  • Table 114. Oncology Ablation Microwave Ablation , by Region USD Million (2025-2030)
  • Table 115. Oncology Ablation Cryoablation , by Region USD Million (2025-2030)
  • Table 116. Oncology Ablation Laser Ablation , by Region USD Million (2025-2030)
  • Table 117. Oncology Ablation High-Intensity Focused Ultrasound (HIFU) , by Region USD Million (2025-2030)
  • Table 118. Oncology Ablation: by Application(USD Million)
  • Table 119. Oncology Ablation Liver Cancer , by Region USD Million (2025-2030)
  • Table 120. Oncology Ablation Kidney Cancer , by Region USD Million (2025-2030)
  • Table 121. Oncology Ablation Prostate Cancer , by Region USD Million (2025-2030)
  • Table 122. Oncology Ablation Bone Cancer , by Region USD Million (2025-2030)
  • Table 123. Oncology Ablation Lung Cancer , by Region USD Million (2025-2030)
  • Table 124. Oncology Ablation Others , by Region USD Million (2025-2030)
  • Table 125. Oncology Ablation: by End User(USD Million)
  • Table 126. Oncology Ablation Hospitals , by Region USD Million (2025-2030)
  • Table 127. Oncology Ablation Specialty Clinics , by Region USD Million (2025-2030)
  • Table 128. Oncology Ablation Ambulatory Surgical Centers , by Region USD Million (2025-2030)
  • Table 129. Oncology Ablation Others , by Region USD Million (2025-2030)
  • Table 130. South America Oncology Ablation, by Country USD Million (2025-2030)
  • Table 131. South America Oncology Ablation, by Type USD Million (2025-2030)
  • Table 132. South America Oncology Ablation, by Application USD Million (2025-2030)
  • Table 133. South America Oncology Ablation, by End User USD Million (2025-2030)
  • Table 134. Brazil Oncology Ablation, by Type USD Million (2025-2030)
  • Table 135. Brazil Oncology Ablation, by Application USD Million (2025-2030)
  • Table 136. Brazil Oncology Ablation, by End User USD Million (2025-2030)
  • Table 137. Argentina Oncology Ablation, by Type USD Million (2025-2030)
  • Table 138. Argentina Oncology Ablation, by Application USD Million (2025-2030)
  • Table 139. Argentina Oncology Ablation, by End User USD Million (2025-2030)
  • Table 140. Rest of South America Oncology Ablation, by Type USD Million (2025-2030)
  • Table 141. Rest of South America Oncology Ablation, by Application USD Million (2025-2030)
  • Table 142. Rest of South America Oncology Ablation, by End User USD Million (2025-2030)
  • Table 143. Asia Pacific Oncology Ablation, by Country USD Million (2025-2030)
  • Table 144. Asia Pacific Oncology Ablation, by Type USD Million (2025-2030)
  • Table 145. Asia Pacific Oncology Ablation, by Application USD Million (2025-2030)
  • Table 146. Asia Pacific Oncology Ablation, by End User USD Million (2025-2030)
  • Table 147. China Oncology Ablation, by Type USD Million (2025-2030)
  • Table 148. China Oncology Ablation, by Application USD Million (2025-2030)
  • Table 149. China Oncology Ablation, by End User USD Million (2025-2030)
  • Table 150. Japan Oncology Ablation, by Type USD Million (2025-2030)
  • Table 151. Japan Oncology Ablation, by Application USD Million (2025-2030)
  • Table 152. Japan Oncology Ablation, by End User USD Million (2025-2030)
  • Table 153. India Oncology Ablation, by Type USD Million (2025-2030)
  • Table 154. India Oncology Ablation, by Application USD Million (2025-2030)
  • Table 155. India Oncology Ablation, by End User USD Million (2025-2030)
  • Table 156. South Korea Oncology Ablation, by Type USD Million (2025-2030)
  • Table 157. South Korea Oncology Ablation, by Application USD Million (2025-2030)
  • Table 158. South Korea Oncology Ablation, by End User USD Million (2025-2030)
  • Table 159. Taiwan Oncology Ablation, by Type USD Million (2025-2030)
  • Table 160. Taiwan Oncology Ablation, by Application USD Million (2025-2030)
  • Table 161. Taiwan Oncology Ablation, by End User USD Million (2025-2030)
  • Table 162. Australia Oncology Ablation, by Type USD Million (2025-2030)
  • Table 163. Australia Oncology Ablation, by Application USD Million (2025-2030)
  • Table 164. Australia Oncology Ablation, by End User USD Million (2025-2030)
  • Table 165. Rest of Asia-Pacific Oncology Ablation, by Type USD Million (2025-2030)
  • Table 166. Rest of Asia-Pacific Oncology Ablation, by Application USD Million (2025-2030)
  • Table 167. Rest of Asia-Pacific Oncology Ablation, by End User USD Million (2025-2030)
  • Table 168. Europe Oncology Ablation, by Country USD Million (2025-2030)
  • Table 169. Europe Oncology Ablation, by Type USD Million (2025-2030)
  • Table 170. Europe Oncology Ablation, by Application USD Million (2025-2030)
  • Table 171. Europe Oncology Ablation, by End User USD Million (2025-2030)
  • Table 172. Germany Oncology Ablation, by Type USD Million (2025-2030)
  • Table 173. Germany Oncology Ablation, by Application USD Million (2025-2030)
  • Table 174. Germany Oncology Ablation, by End User USD Million (2025-2030)
  • Table 175. France Oncology Ablation, by Type USD Million (2025-2030)
  • Table 176. France Oncology Ablation, by Application USD Million (2025-2030)
  • Table 177. France Oncology Ablation, by End User USD Million (2025-2030)
  • Table 178. Italy Oncology Ablation, by Type USD Million (2025-2030)
  • Table 179. Italy Oncology Ablation, by Application USD Million (2025-2030)
  • Table 180. Italy Oncology Ablation, by End User USD Million (2025-2030)
  • Table 181. United Kingdom Oncology Ablation, by Type USD Million (2025-2030)
  • Table 182. United Kingdom Oncology Ablation, by Application USD Million (2025-2030)
  • Table 183. United Kingdom Oncology Ablation, by End User USD Million (2025-2030)
  • Table 184. Netherlands Oncology Ablation, by Type USD Million (2025-2030)
  • Table 185. Netherlands Oncology Ablation, by Application USD Million (2025-2030)
  • Table 186. Netherlands Oncology Ablation, by End User USD Million (2025-2030)
  • Table 187. Rest of Europe Oncology Ablation, by Type USD Million (2025-2030)
  • Table 188. Rest of Europe Oncology Ablation, by Application USD Million (2025-2030)
  • Table 189. Rest of Europe Oncology Ablation, by End User USD Million (2025-2030)
  • Table 190. MEA Oncology Ablation, by Country USD Million (2025-2030)
  • Table 191. MEA Oncology Ablation, by Type USD Million (2025-2030)
  • Table 192. MEA Oncology Ablation, by Application USD Million (2025-2030)
  • Table 193. MEA Oncology Ablation, by End User USD Million (2025-2030)
  • Table 194. Middle East Oncology Ablation, by Type USD Million (2025-2030)
  • Table 195. Middle East Oncology Ablation, by Application USD Million (2025-2030)
  • Table 196. Middle East Oncology Ablation, by End User USD Million (2025-2030)
  • Table 197. Africa Oncology Ablation, by Type USD Million (2025-2030)
  • Table 198. Africa Oncology Ablation, by Application USD Million (2025-2030)
  • Table 199. Africa Oncology Ablation, by End User USD Million (2025-2030)
  • Table 200. North America Oncology Ablation, by Country USD Million (2025-2030)
  • Table 201. North America Oncology Ablation, by Type USD Million (2025-2030)
  • Table 202. North America Oncology Ablation, by Application USD Million (2025-2030)
  • Table 203. North America Oncology Ablation, by End User USD Million (2025-2030)
  • Table 204. United States Oncology Ablation, by Type USD Million (2025-2030)
  • Table 205. United States Oncology Ablation, by Application USD Million (2025-2030)
  • Table 206. United States Oncology Ablation, by End User USD Million (2025-2030)
  • Table 207. Canada Oncology Ablation, by Type USD Million (2025-2030)
  • Table 208. Canada Oncology Ablation, by Application USD Million (2025-2030)
  • Table 209. Canada Oncology Ablation, by End User USD Million (2025-2030)
  • Table 210. Mexico Oncology Ablation, by Type USD Million (2025-2030)
  • Table 211. Mexico Oncology Ablation, by Application USD Million (2025-2030)
  • Table 212. Mexico Oncology Ablation, by End User USD Million (2025-2030)
  • Table 213. Research Programs/Design for This Report
  • Table 214. Key Data Information from Secondary Sources
  • Table 215. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Oncology Ablation: by Type USD Million (2018-2023)
  • Figure 5. Global Oncology Ablation: by Application USD Million (2018-2023)
  • Figure 6. Global Oncology Ablation: by End User USD Million (2018-2023)
  • Figure 7. South America Oncology Ablation Share (%), by Country
  • Figure 8. Asia Pacific Oncology Ablation Share (%), by Country
  • Figure 9. Europe Oncology Ablation Share (%), by Country
  • Figure 10. MEA Oncology Ablation Share (%), by Country
  • Figure 11. North America Oncology Ablation Share (%), by Country
  • Figure 12. Global Oncology Ablation share by Players 2023 (%)
  • Figure 13. Global Oncology Ablation share by Players (Top 3) 2023(%)
  • Figure 14. Global Oncology Ablation share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Varian Medical Systems, Inc. Revenue, Net Income and Gross profit
  • Figure 17. Varian Medical Systems, Inc. Revenue: by Geography 2023
  • Figure 18. Johnson & Johnson Services Inc. Revenue, Net Income and Gross profit
  • Figure 19. Johnson & Johnson Services Inc. Revenue: by Geography 2023
  • Figure 20. Medtronic Revenue, Net Income and Gross profit
  • Figure 21. Medtronic Revenue: by Geography 2023
  • Figure 22. Boston Scientific Corporation Revenue, Net Income and Gross profit
  • Figure 23. Boston Scientific Corporation Revenue: by Geography 2023
  • Figure 24. Marcus Med Revenue, Net Income and Gross profit
  • Figure 25. Marcus Med Revenue: by Geography 2023
  • Figure 26. Olympus Revenue, Net Income and Gross profit
  • Figure 27. Olympus Revenue: by Geography 2023
  • Figure 28. Stryker Revenue, Net Income and Gross profit
  • Figure 29. Stryker Revenue: by Geography 2023
  • Figure 30. Canyon Medical Inc. Revenue, Net Income and Gross profit
  • Figure 31. Canyon Medical Inc. Revenue: by Geography 2023
  • Figure 32. Surgnova Revenue, Net Income and Gross profit
  • Figure 33. Surgnova Revenue: by Geography 2023
  • Figure 34. Hologic, Inc. Revenue, Net Income and Gross profit
  • Figure 35. Hologic, Inc. Revenue: by Geography 2023
  • Figure 36. Global Oncology Ablation: by Type USD Million (2025-2030)
  • Figure 37. Global Oncology Ablation: by Application USD Million (2025-2030)
  • Figure 38. Global Oncology Ablation: by End User USD Million (2025-2030)
  • Figure 39. South America Oncology Ablation Share (%), by Country
  • Figure 40. Asia Pacific Oncology Ablation Share (%), by Country
  • Figure 41. Europe Oncology Ablation Share (%), by Country
  • Figure 42. MEA Oncology Ablation Share (%), by Country
  • Figure 43. North America Oncology Ablation Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Varian Medical Systems, Inc.
  • Johnson & Johnson Services Inc.
  • Medtronic
  • Boston Scientific Corporation
  • Marcus Med
  • Olympus
  • Stryker
  • Canyon Medical Inc.
  • Surgnova
  • Hologic, Inc.
Additional players considered in the study are as follows:
Merit Medical Systems , Terumo Corporation , AngioDynamics , Francis Medical, Inc. , Sonablate Corp. , Vascular & International Partners
Select User Access Type

Key Highlights of Report


Oct 2024 200 Pages 94 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Oncology Ablation Quantitative research analysis
Global Oncology Ablation Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Due to pricing constraints we only profile limited players in the study that includes a mix list of leaders and emerging players, however for evaluation of market size the coverage includes 100+ players.
Yes, the study does represent market size by key business segment, application/end users and major geographies forecasted till 2030
The Study can be customized to meet your requirements. Please connect with our representative, in case you wish to add or remove certain country or profiled players.
  • High initial investment for advanced ablation technologies

Know More About Global Oncology Ablation Report?

Have a Query? Click Here

Other Related Reports

Clinical Data Analytics in Healthcare Comprehensive Study by Type (Software, Services), Application (Quality Improvement and Clinical Benchmarking, Clinical Decision Support, Regulatory Reporting and...
$ 3750
Test Tube Baby Comprehensive Study by Type (Reagents (Embryo culture media, Cryopreservation media, Sperm processing media, Ovum processing media), Equipment (Imaging system, Sperm separation system,...
$ 3750
Medical Laser Technology Comprehensive Study by Type (Solid state laser system, Diode laser system, Dye laser system, Gas laser system), Application (Diagnostic, Surgical, Cosmetic, Therapeutic, Dent...
$ 3800
Virtual Reality in Tourism Comprehensive Study by Type (Head Mount Device, Gesture Tracking Device), Application (Travel Agency, Hotel, Tourist Attractions, Other), Video Type (Monoscopic VR Tourism ...
$ 3800
Surgical Simulator Comprehensive Study by Type (Human Patient Simulators, Screen-based simulators), Application (Laparoscopic Surgery, Neurosurgery, Endoscopic Surgery, Trauma Surgery, Cardiac Surger...
$ 3650
Excimer Laser Comprehensive Study by Type (Argon Laser, Fluoride Laser, Others), Application (Ophthalmology, Dermatology, Photolithography, Scientific Research, Others), Industry Verticals (Healthcar...
$ 3450